J. Gao (Stockholm, Sweden), T. Guney (London, United Kingdom), C. Caballero Eraso (Sevilla, Spain), I. Satia (Hamilton (ON), Canada)
Blood eosinophil as a biomarker in COPD
J. Park (Suwon, Republic of Korea), Y. Hong (Chuncheon, Republic of Korea), W. Kim (Chuncheon, Republic of Korea), S. Um (Busan, Republic of Korea), J. Jung (Suwon, Republic of Korea), S. Ahn (Wonju, Republic of Korea), Y. Oh (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
|   |
Eosinophil count on admission is not a good biomarker in severe exacerbations of COPD to predic later readmission: a long term observational study from the AECOPD-Barcelona Cohort
A. Huerta Garcia (Barcelona, Spain), P. Marcos (La Coruña, Spain), A. Ceccato (Barcelona, Spain), L. Pinyol (Barcelona, Spain), M. Guerrero (Barcelona, Spain), O. Vilaro (Barcelona, Spain), A. Gabarrus (Barcelona, Spain), C. Sanchez (Barcelona, Spain), E. Gomez-Angelats (Barcelona, Spain), N. Soler (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Characteristics of COPD patients treated with inhaled corticosteroid in primary care
O. Savran (Hvidovre, Denmark), N. Skavlan Godtfredsen (Hvidovre, Denmark), T. Sørensen (Værløse, Denmark), C. Jensen (Præstø, Denmark), C. Suppli Ulrik (Hvidovre, Denmark)
| |
Bronchiectasis contributes to the severity of COPD
A. Dimakou (Athens, Greece), M. Kaponi (Athens, Greece), K. Tsikritsaki (Athens, Greece), A. Gousiou (Athens, Greece), S. Chrysikos (Athens, Greece), G. Hillas (Athens, Greece), X. Triantafyllidou (Athens, Greece), T. Karampitsakos (Athens, Greece), L. Thanos (Athens, Greece), M. Toumbis (Athens, Greece)
| |
Residual reversibility in COPD subjects treated by long acting bronchodilatators
M. Picaud (Lille, France), O. Le Rouzic (Lille, France), H. Salvator (Suresnes, France), H. Neveu (Suresnes, France), P. Devillier (Suresnes, France), L. Couderc (Suresnes, France), T. Perez (Lille, France)
| |
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis
F. Malli (Larissa, Greece), O. Kotsiou (Larissa, Greece), A. Gouvani (Larissa, Greece), S. Ladias (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), Z. Daniil (Larissa, Greece)
| |
Assessment of health status using CAT scores in COPD patients from Italy: the MISTRAL study
P. Morini (Origgio, Italy), M. Agneni (ASL, Roma1, Italy), P. Patriciello (Pollena Trocchia, NA, Italy), A. Triani (Bolzano, Italy), P. Balbo (Novara, Italy), R. Refini (Siena, SI, Italy), M. Bartezaghi (Origgio, Italy), A. Porpiglia (Origgio, Italy)
| |
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
A. Hedhliabir (Ariana, Tunisia), A. Slim (Ariana, Tunisia), S. Cheikh Rouhou (Ariana, Tunisia), S. Ben Khaled (Ariana, Tunisia), A. Taboubi (Ariana, Tunisia), Y. Ouahchi (Ariana, Tunisia), J. Cherif (Ariana, Tunisia), S. Toujani (Ariana, Tunisia), M. Mjid (Ariana, Tunisia), S. Merai (Ariana, Tunisia)
| |
Exhaled nitric oxide as a biomarker in different COPD phenotypes
I. Markelic (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), S. Popovic-Grle (Zagreb, Croatia), B. Cuk (Zagreb, Croatia), A. Hecimovic (Zagreb, Croatia), M. Jankovic-Makek (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia)
| |
Periostin levels in chronic obstructive pulmonary disease (COPD)
S. Nakamura (Nagoya, Japan), K. Wakahara (Nagoya, Japan), S. Majima (Nagoya, Japan), T. Nisio (Nagoya, Japan), Y. Suzuki (Kariya, Japan), A. Shiraki (Ogaki, Japan), T. Abe (Ogaki, Japan), J. Shindoh (Ogaki, Japan), T. Sashio (Nagoya, Japan), J. Ono (Sagamihara, Japan), K. Izuhara (Saga, Japan), Y. Hasegawa (Nagoya, Japan)
| |
Repeatability of multiple breath washout measurements in stable Chronic Obstructive Pulmonary Disease.
E. Daynes (Leicester, United Kingdom), M. Soares (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom), J. Owers-Bradley (Nottingham, United Kingdom), S. Singh (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom)
| |
Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?
H. Yakar (Istanbul, Turkey), A. Kanbay (Istanbul, Turkey), E. Ceylan (Istanbul, Turkey)
| |
Eosinophils and different clusters in COPD patients.
J. William Zucchi (Botucatu, Brazil), B. Evelyn Bueno De Morais (Botucatu, Brazil), T. Garcia (Botucatu, Brazil), L. Henrique Soares Machado (Botucatu, Brazil), A. Natalia Ribeiro Batista (Botucatu, Brazil), E. Aparecida Thome Franco (Botucatu, Brazil), I. Godoy (Botucatu, Brazil), S. Erico Tanni (Botucatu, Brazil)
| |
Clinical correlates of alveolar nitric oxide in COPD
A. Thornadtsson (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), K. BröMs (Gävle, Sweden), K. Lisspers (Uppsala, Sweden), B. StäLlberg (Uppsala, Sweden), C. Janson (Uppsala, Sweden), M. HöGman (Uppsala, Sweden)
| |
Glycated hemoglobin (HbA1c) and acute exacerbation in chronic obstructive pulmonary disease: a potent biomarker of severity and prognosis. Preliminary data.
E. Papathanassiou (Athens , Greece), A. Papaioannou (Athens, Greece), G. Hillas (Athens, Greece), E. Mizi (Athens , Greece), P. Bakakos (Athens, Greece), V. Apollonatou (Athens, Greece), G. Verykokou (Athens, Greece), N. Roussakis (Athens, Greece), Z. Tsilogianni (Athens, Greece), K. Kostikas (Athens, Greece), S. Papiris (Athens, Greece), S. Loukides (Athens, Greece)
| |
Characterisation of UK and US COPD populations in reference to exacerbation frequency and blood eosinophils level
C. Vogelmeier (Marburg, Germany), K. Kostikas (Basel, Switzerland), J. Fang (East Hanover, United States of America), B. Jones (Cardiff, United Kingdom), C. Morgan (Cardiff, United Kingdom), R. Fogel (East Hanover, United States of America), F. Gutzwiller (Basel, Switzerland), H. Cao (East Hanover, United States of America)
| |
Overnight changes in exhaled carbon monoxide levels in obstructive sleep apnoea
M. Meszaros (Budapest, Hungary), A. Kis (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), P. Horvath (Budapest, Hungary), Z. Lazar (Budapest, Hungary), L. Kunos (Budapest, Hungary), A. Bikov (Budapest, Hungary)
| |
The influence of different degrees of body mass index on respiratory system impedance
M. Holtz De Paula (Ribeirão Preto, Brazil), L. Perossi (Ribeirão Preto, Brazil), D. Santos (Ribeirão Preto, Brazil), A. Lago (Ribeirão Preto, Brazil), J. Baddini-Martinez (Ribeirão Preto, Brazil), A. Gastaldi (Ribeirão Preto, Brazil)
| |